Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
People Who Inject Drugs Can Be Linked to Hepatitis C Treatment During Hospitalization
Initiating HCV treatment during a hospital stay helped more people complete antiviral treatment and achieve a cure. More
Age, Baseline Fibrosis Can Predict Fibrosis Regression with DAA Use
Fibrosis regression is prevalent among 57% of the cohort and is associated with older age and advanced fibrosis at baseline. More
Antiviral Therapy Reduces Risk of Cardiovascular Outcomes in Patients with HCV
Use of antiviral therapy is linked to a decreased risk of multiple cardiovascular outcomes and mortality compared to patients not using antiviral therapy. More
Long-Term Benefit of DAAs on Gut Dysbiosis and Microbial Translocation
Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection More
Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
An article in 2023 issue of TAGline explores how to reimagine HCV elimination strategies now that intellectual property is no longer restricting access to generic cures. More
Public Reimbursement Policies in Canada for Direct-Acting Antiviral Treatment for Hepatitis C
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study More
Direct-Acting Antivirals Prove Long-Acting on HCV Infection after Liver Transplant
Long-term follow-up of direct-acting antiviral treatment of HCV infection after liver transplant shows persistent improvement in hepatic function, fibrosis, and survival rate. More
The Impact of Expanded Access to DAAs for Hepatitis C Virus on Patient Outcomes in Canada
A study evaluated the early change in rates of HCV-related hospitalizations overall and HCV-related hospitalizations with hepatocellular carcinoma after expanded access to DAAs in Canada. More
Prospects for Long-Acting Treatments for Hepatitis C
Long-acting parenteral formulations of HCV treatment may allow people living with hepatitis C virus infection to be diagnosed and cured in a single encounter. More
Managing Hepatitis C in Treatment-Naïve Patients with HIV Coinfection
An article gives an overview of the recommendations for the management of patients with HIV/HCV coinfection in the context of the United States. More
